Status:
COMPLETED
Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment
Lead Sponsor:
Bayer
Conditions:
Relapsing Remitting Multiple Sclerosis (RRMS)
Eligibility:
All Genders
12+ years
Brief Summary
* The Study analyses the influence of selected factors on adherence to Betaferon treatment in patients with early multiple sclerosis (MS). The Investigator will document the relevant medical data rega...
Eligibility Criteria
Inclusion
- Patients after first clinical event suggestive of multiple Sclerosis (MS) (according to SmPC) and patients with Relapsing / Remitting Multiple Sclerosis (RRMS) within the first two years of diagnosis.
Exclusion
- Contra-indications as indicated in Betaferon summary of Products Characteristics (SmPC)
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
1723 Patients enrolled
Trial Details
Trial ID
NCT00787657
Start Date
June 1 2008
End Date
October 1 2014
Last Update
October 16 2015
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Argentina
2
Many Locations, Bahrain
3
Many Locations, Belgium
4
Many Locations, Bosnia and Herzegovina